Angelman syndrome results from the loss or malfunction of a single gene called UBE3A on chromosome 15, and the inheritance pattern is unusual because it only matters when the mother’s copy is affected. You inherit two copies of this gene, one from each parent, but in brain cells only the maternal copy is active. The paternal copy is naturally silenced. This means that if something goes wrong with the copy you got from your mother, your brain cells can’t produce the protein at all, even though the father’s copy is technically sitting right there in your DNA.
Angelman syndrome occurs in roughly 1 in 15,000 live births. There are several different genetic mechanisms that cause it, and each one carries a different risk of happening again in future pregnancies.
Why Only the Mother’s Copy Matters
Most genes work the same regardless of which parent they came from. But a small percentage of human genes are subject to a process called genomic imprinting, where one parent’s copy is chemically tagged and switched off. During the formation of eggs and sperm, small molecules called methyl groups attach to specific stretches of DNA, essentially marking which copy came from mom and which came from dad. These marks control whether a gene is active or silent.
The UBE3A gene sits in a well-known cluster of imprinted genes on the long arm of chromosome 15, in a region called 15q11-q13. In most tissues throughout the body, both copies of UBE3A are active and working normally. But in neurons of the brain and spinal cord, the father’s copy is silenced by imprinting. Only the mother’s copy produces the protein these cells need.
That protein, ubiquitin protein ligase E3A, acts like a cleanup crew inside nerve cells. It tags damaged or unneeded proteins with a small molecule called ubiquitin, marking them for disposal. This recycling process is especially important at synapses, the junctions where nerve cells communicate with each other. Keeping the balance of proteins at synapses in check allows those connections to strengthen or weaken in response to experience, which is the foundation of learning and memory. When neurons can’t make this enzyme, that process breaks down.
The Four Genetic Causes
There isn’t a single genetic event behind every case. Angelman syndrome can arise through four distinct mechanisms, each disrupting the maternal UBE3A gene in a different way.
Deletion of the Maternal Chromosome Region
The most common cause, accounting for roughly 70 to 90 percent of cases, is a deletion. A chunk of the mother’s chromosome 15, spanning the 15q11-q13 region, is simply missing. Because the father’s copy of UBE3A is already silenced in brain cells, this deletion leaves neurons with no working copy of the gene at all. The vast majority of these deletions happen spontaneously during the formation of the egg or early embryonic development. They are not inherited from the mother’s own DNA.
Paternal Uniparental Disomy
In a small number of cases, the child inherits two copies of chromosome 15 from the father and none from the mother. This is called uniparental disomy. Even though both copies of UBE3A are structurally normal, they are both paternal copies, so both are silenced in brain cells. The result is the same: no functional UBE3A protein in neurons. Over 99 percent of these cases occur as spontaneous events, not something passed down through a family.
Imprinting Center Defects
A small region of DNA near UBE3A, called the imprinting center, controls whether the gene gets switched on or off. If this control region is damaged or altered on the maternal chromosome, the mother’s copy of UBE3A can be incorrectly silenced, as though it were a paternal copy. Some of these defects happen spontaneously and carry less than a 1 percent chance of recurring. However, a significant proportion of imprinting center deletions are inherited from the mother, and these carry a 50 percent recurrence risk in future pregnancies.
UBE3A Gene Mutations
Sometimes the maternal copy of chromosome 15 is intact and properly imprinted, but the UBE3A gene itself contains a mutation that prevents it from producing a working protein. These point mutations can either arise spontaneously (with no increased risk of recurrence) or be inherited from the mother, who may carry the mutation without being affected because her other copy of UBE3A compensates in her own brain. When the mutation is inherited, each future pregnancy has a 50 percent chance of being affected.
Why the Genetic Subtype Matters for Families
The practical difference between these four mechanisms comes down to recurrence risk. For the most common cause, a spontaneous deletion, the chance of having another child with Angelman syndrome is less than 1 percent. The same is true for paternal uniparental disomy. But inherited imprinting center defects and inherited UBE3A mutations each carry a 50 percent recurrence risk, because the mother passes on the problematic chromosome half the time.
This is why genetic testing does more than confirm a diagnosis. It tells families which mechanism is responsible, which directly shapes counseling about future pregnancies. About 10 percent of people with the classic features of Angelman syndrome have no identifiable genetic cause with current testing methods, which can make counseling more difficult.
How Genetic Testing Works
The first test typically ordered is a DNA methylation analysis. This test checks whether the chemical imprinting marks on chromosome 15 are normal. It can detect deletions, uniparental disomy, and imprinting defects all in one step, because all three result in an abnormal methylation pattern. It picks up the cause in the majority of cases.
If methylation results come back normal but clinical suspicion remains strong, the next step is direct sequencing of the UBE3A gene to look for point mutations. If no mutation is found through sequencing, additional testing can check for smaller deletions within the gene itself. This layered approach catches progressively rarer causes, working from the most common mechanism to the least.
Why Fathers Can Carry the Same Changes Without Risk
One of the more counterintuitive aspects of Angelman syndrome is that a father can carry a UBE3A mutation or an imprinting defect and never pass the condition to his children. Because the paternal copy of UBE3A is silenced in brain cells regardless, a defective paternal copy has no effect. The risk only emerges when that mutation is passed from the father to a daughter, who could then pass it to her own children as a maternal copy. This is why the condition can seem to skip generations, appearing only when the affected gene travels through a female line and lands in a child as the maternal contribution.
This also explains why a mother who carries a UBE3A mutation may show no symptoms herself. She has two copies of the gene, and her maternal copy (from her own mother) is functioning normally in her brain cells. The mutation sits on her paternal copy, which is silenced anyway. But when she passes that mutated copy to her child, it becomes the child’s maternal copy, the only one that matters in the brain.